Discussion on radiation protection and critical control techniques on 125I seed implantation
ZHANG Zaoqin1, FU Qiang2, GENG Jiwu1, XU Zhiqiang1, WANG Meixia1, XIA Bing1
1. Guangdong Province Hospital for Occupational Disease Prevention And Treatment, Institute of Occupational Health Assessment, Guangzhou 510300 China; 2. Qingdao Municipal Hospital
[1] Liang Y, Wang Z, Zhang H, et al. Three-dimensional-printed individual template-guided 125I seed implantation for the cervical lymph node metastasis:A dosimetric and security study[J].J Cancer Res Ther,2018,14(1):30-35. [2] 魏澜波,李正才,陈大伟.放射性粒籽植入治疗前列腺癌辐射防护新进展[J].中国辐射卫生,2014,21(4):504-506. [3] 钱和,王文捷.HACCP原理与实施[M].北京:中国轻工业出版社,2009. [4] Kenichi TANAKA,satoru ENDO. Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy[J].Journal of radiation Research,2014,55(1):162-167. [5] Knon Y, Miyamoto Y, Oohashi S,et al. Radiation exposure to general public after permanent brachytherapy for prostate cancer[J].Radiat Prot Dosimetry,2011,146(1-3):229-230. [6] 国家技术监督局.GB 11806-2004放射性物质安全运输规程[S].北京:中国国家标准出版社,2004. [7] 陈清凤,陈飞宇,陈以水,等.某医院125I粒籽源植入项目放射防护效果验证与探讨[J].中国辐射卫生,2017,26(2):184-186. [8] 岳瑶,刘海生,王俊杰,等.125I粒子植入前装载过程中医护人员的剂量监测[J].中华放射医学与防护杂志,2015,35(7):536-538. [9] 耿建华,曹仲年,赵卫强,等. 125I粒子植入前装载过程中工作人员受照剂量的研究[J].中国医学装备,2012,9(10):1-3. [10] 孟庆华,马永忠,万玲,等.125I放射性粒子植入治疗中工作人员受照剂量测量与分析[J].首都公共卫生,2013,7(5):202-204. [11] 岳保荣,范瑶华,娄云,等.放射诊疗中职业危害控制关键技术与风险评价研究[J]. 中华放射医学与防护杂志,2011,31(4):384-386. [12] 尉可道.风险管理及其对医疗器械的应用[J].中国医学装备,2004,1(2):14-17. [13] 邓君,范瑶华,岳保荣.高剂量率后装放疗概率安全评价(PSA)技术及应用[J].中华放射医学与防护杂志,2010,30(6):728-731. [14] 李秀芹,赵进沛,吴欣,等.军队放射卫生监督监测HACCP质量保证体系的建立[J].职业与健康,2013,29(8):1007-1011. [15] 陈克敏,王忠敏等.放射性粒子植入技术临床应用[M].北京:科学出版社,2011.